Page last updated: 2024-11-07
1,4-phenanthrenequinone
Description
1,4-Phenanthrenequinone is a yellow crystalline solid with a melting point of 206–207 °C. It is synthesized by oxidation of phenanthrene, often using chromic acid. It is a versatile compound with a rich chemistry, serving as a building block for a variety of other compounds. 1,4-Phenanthrenequinone has been studied for its potential biological activity, including its ability to act as a DNA intercalator and to inhibit the growth of certain cancer cells. It has also been investigated for its photophysical properties, including its ability to fluoresce and to undergo photoreduction. Researchers are interested in studying 1,4-phenanthrenequinone because of its potential applications in organic electronics, pharmaceuticals, and materials science.'
1,4-phenanthrenequinone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 98574 |
SCHEMBL ID | 64776 |
MeSH ID | M0276246 |
Synonyms (21)
Synonym |
c14h8o2 |
phenanthrene-1,4-quinone |
5,8-phenanthraquinone |
1,4-phenanthrenequinone |
nsc 148970 |
1,4-phenanthroquinone |
brn 1871015 |
1,4-phenanthraquinone |
1,4-phenanthrenedione |
nsc-148970 |
nsc148970 |
569-15-3 |
phenanthrene-1,4-dione |
2-07-00-00724 (beilstein handbook reference) |
unii-iu5xp36k84 |
iu5xp36k84 , |
SCHEMBL64776 |
DTXSID40205431 |
FT-0749369 |
dimeflinehcl |
1,4-dihydrophenanthrene-1,4-dione |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.54
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.54 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.73 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |